RVTY Revvity: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

revvity.com - graphic logo of issuer RVTY

The diversification of Revvity, Inc. (RVTY) diagnostic systems ensures stable revenue, which is confirmed by growth in the Enterprise Value to EBITDA multiple on the GURU.Markets platform, where the 23.03 mark reflects the current state. The business foundation is based on an impeccable B2B reputation in science and the implementation of green manufacturing standards to reduce harmful emissions.

PerkinElmer - RVTY Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/10/2026)

Comprehensive metric breakdowns and analytics for revvity.com (RVTY)

- stock price and consensus target price:
Stock Quotes PerkinElmer|RVTY - Average Forecast Price
- company stock capitalization data:
Market Value Revvity Corp|RVTY - Company Buyout Price
- book value of equity indicators:
Book Value per Share Revvity|RVTY - Book Valuation of Business|Market Value to Book Value Ratio revvity.com|RVTY - Company Total Asset Base
- company liabilities and liquidity data:
Debt to Equity Revvity, Inc.|RVTY - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Revvity|RVTY - Company Cumulative Debt|Debt to Book Value Revvity Corp|RVTY - Company Long-Term Debt|Company Current Liabilities Revvity|Quick Ratio revvity.com
- financial results and valuation multiples details:
RVTY - Net Financial Result|Future Profit Revvity, Inc.|RVTY - Market Price to Net Income Ratio|Projected Price to Earnings Revvity, Inc.|RVTY - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Revvity Corp|RVTY - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Revvity|RVTY - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months revvity.com|RVTY - Earnings per share growth this year|Earnings growth forecast for next year Revvity, Inc.
Initial company analysis:PerkinElmer (RVTY)
Original product of revvity.com

The investment appeal of Revvity, Inc. (RVTY) is based on its unique technological specialization in high-precision diagnostics. The EV/EBITDA metric compares the total enterprise value with operating profit before depreciation, taxes, and interest. By analyzing the EV/EBITDA ratio trend, an investor can assess the company's maturity stage and the stability of its cash flows. The stability of this indicator confirms the protection of market share against price competition and the fundamental strength of the business.

Who Revvity, Inc. competes with

Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|BIO: EV/EBITDA Multiple|NNNN - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sterigenics|QuidelOrtho Inc. (QDEL) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OPKO Health, Inc. (OPK)|CDNA (CareDx, Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple MRVI (Maravai LifeSciences Holdings, Inc.)|Fulgent Genetics Inc (FLGT) - Company Value to EBITDA|LAB: Enterprise Value to EBITDA Ratio|CTKB: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|OSUR (OraSure Technologies) - Enterprise Value to EBITDA Ratio|XGN (Exagen) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDXH (MDxHealth) - EV/EBITDA Multiple|Lucid Diagnostics, Inc. (LUCD) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio PRE (Prenetics Global)|Enterprise Value to Operating Income Before Depreciation Ratio IMDX|Trinity Biotech - Enterprise Value to EBITDA Ratio|prophaselabs.com (PRPH) - Company Value to EBITDA|AIMD: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation CODX (Co-Diagnostics Inc)|HSCS: EV/EBITDA Multiple|BMRA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cardio Diagnostics Holdings Inc.|Enterprise Value to Operating Income Before Depreciation ONCO (onconetix.gcs-web.com)|EV/EBITDA Multiple VRAX|Enterprise Value to EBITDA Ratio Bluejay Diagnostics Inc BJDX|Vermillion - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Accelerate Diagnostics Inc (AXDX)|CNTG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation ENZ (Enzo Biochem, Inc.)|FRES (fresh2.co) - Enterprise Value to EBITDA Ratio|GENE (Genetic Technologies Limited) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ME|PMD (Psychemedics Inc) - Enterprise Value to Operating Income Before Depreciation Ratio